However, the prognosis for CRC has improved because intensive follow-up strategies using colonoscopy and carcinoembryonic antigen (CEA) monitoring reduce overall mortality and increase the chances of performing curative surgery for recurrences [28,29]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.